Skip to main content

Trump puts Pence in charge of coronavirus efforts, calls risk to Americans ‘very low’

President Donald Trump declared Wednesday that the U.S. is “very, very ready” for whatever the coronavirus threat brings, and he put his vice president in charge of overseeing the nation’s response.

Trump sought to minimize fears of the virus spreading widely across the U.S. But he said he was ready to spend “whatever’s appropriate,” even if that meant the extra billions of dollars that Democrats have said is necessary to beef up the U.S. response. Trump had told Congress earlier this week that the government needed to spend $2.5 billion to fight the virus.

“We’re very, very ready for this, for anything,” even if it’s “a breakout of larger proportions,” Trump told a news conference.

Vice President Mike Pence will be working with the government’s top health authorities, and Trump’s earlier-appointed coronavirus task force, to oversee the response.

More must-read stories from Fortune:

—Are we undergoing an industrial revolution or a phase change?
—Understanding the 2020 election as brand marketing
—Investors shouldn’t underestimate election volatility, warns UBS
—Angela Merkel is on her way out. Meet her potential replacements
—How the 2020 election could influence your personal finances

Get up to speed on your morning commute with Fortune’s CEO Daily newsletter.



from Fortune https://ift.tt/2T2hui5
Labels:

Comments

Post a Comment

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $
Post a Comment
Read more

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be
Post a Comment
Read more